We prepared a 5-fluorodeoxyuridine (5-FdUrd) derivative possessing azide methyl group (N 3 -FdUrd) as a novel radiation-activated prodrug. The parent antitumor agent, 5-FdUrd, was released efficiently from N 3 -FdUrd by hypoxic X-irradiation. On the other hand, the activation of N 3 -FdUrd was suppressed upon X-irradiation under aerobic conditions. A biological assay using A549 cells revealed that the cytotoxicity of N 3 -FdUrd was significantly enhanced by hypoxic X-irradiation.
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Prodrugs that are activated by an external stimulus have been attracting much attention.
These prodrugs themselves are nontoxic, but exposure to triggers such as photoirradiation, 1 change in pH 2 or enzymatic reactions 3 bring about changes in the chemical structure of the prodrugs to enable their inherent medical capability. 4 Because of the ease of controlling their functions, stimuli-sensitive prodrugs are prospective high-performing medical agents with mild side effects.
One of the new strategies employed in this area is the utilization of X-irradiation 5 as an external trigger to activate prodrugs. Since chemical reactions triggered by radiation can be controlled spatially and temporary, such prodrugs can be converted to their active forms with exact control of the area, time, and dosage. Recently, we have developed several prodrugs that can be activated by X-irradiation. 6 We prepared prodrugs of the antitumor agents 5-fluorouracil, 5-fluorodeoxyuridine (5-FdUrd), and cytarabine by incorporation of a 2-oxoalkyl group or an indolequinone structure, which are removable by X-ray treatment under hypoxic conditions. A reaction mechanism has been proposed:
these substituents undergo reductive activation by reducing species generated by the radiolysis of water 7 to release their parent drug. These prodrugs showed cytotoxicity 5 towards hypoxic tumor cells upon X-irradiation, while they were nontoxic against aerobic cells, even upon X-irradiation.
Herein, we discuss the design of a novel radiation-activated prodrug of 5-FdUrd possessing azide methyl group (N 3 -FdUrd), which is known to be a removable substituent under reducing conditions. 8 We expected that N 3 -FdUrd would be activated by reducing species generated from radiolysis of water to form aminal 1 (Figure 1 ), which would be hydrolyzed in aqueous solution to give 5-FdUrd. We synthesized the N 3 -FdUrd and characterized its radiolytic reduction behavior. The radation-dependent cytotoxicity of N 3 -FdUrd using living cells was also assessed.
The strategy for preparation of N 3 -FdUrd is summarized in Scheme 1.
Diacetyl-5-fluorodeoxyuridine 2 was coupled with chloromethyl methyl sulfide, and then converted to the azide compound 4. Initially, we performed the radiolytic reduction of N 3 -FdUrd and monitored the reaction using reversed-phase HPLC. 11 We conducted the radiolysis in argon-purged aqueous solutions containing 2-methyl-2-propanol as a scavenger for the oxidizing hydroxyl radicals (OH The properties of N 3 -FdUrd described above prompted us to further investigate the effect of X-irradiation on the cytotoxicity ( Figure 4A ). An aqueous solution of (11) Since the large amount of prodrug and products was necessary to monitor the reaction by HPLC, we conducted the experiment using 300 M prodrugs and high dose of X-irradiation (up to 960 Gy). 
